Bone Marrow TransplantationBone TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsBone and BonesGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalBone RemodelingKidney TransplantationTissue DonorsLeukemiaTransplantation ChimeraLiver TransplantationBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsBone DensityGraft RejectionTransplantation, IsogeneicBone Marrow DiseasesCyclophosphamideImmunosuppressive AgentsRecurrenceHematopoiesisTreatment OutcomeMice, Inbred C57BLHeart TransplantationBone ResorptionCombined Modality TherapyTime FactorsBone Marrow ExaminationRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteHematologic NeoplasmsTransplantation ImmunologyImmunosuppressionBone Marrow NeoplasmsLung TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHepatic Veno-Occlusive DiseaseStem Cell TransplantationLeukemia, MyeloidGraft vs Host ReactionRetrospective StudiesAcute DiseaseLymphocyte DepletionBone NeoplasmsCyclosporineLymphoma, Non-HodgkinLeukocyte TransfusionSurvival AnalysisHLA AntigensBone DevelopmentT-LymphocytesSevere Combined ImmunodeficiencyChimeraBone DiseasesMyelodysplastic SyndromesColony-Forming Units AssayCytomegalovirus InfectionsHematologic DiseasesActuarial AnalysisFollow-Up StudiesTransplantationLymphocyte TransfusionCell DifferentiationSurvival RateAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyTransplantsCarmustinePancytopeniaGraft vs Tumor EffectBone RegenerationLeukocyte CountGraft vs Leukemia EffectOrgan TransplantationMice, Inbred BALB CCytarabineGranulocyte Colony-Stimulating FactorFlow CytometryMelphalanDisease-Free SurvivalMultiple MyelomaPostoperative ComplicationsSpleenCells, CulturedFatal OutcomeLiving DonorsLymphoma